TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/22/22 17:39 | 3/21/22 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Walsh Patrick D | MN | D | P | 139 | 27.76 | 0 | 5 | 10 | 53 | D | |||||||||||||||
4/22/21 16:10 | 4/20/21 | LNDC | Landec Corp ca | CA | FdBev | Food | Canned, Fruits, Veg, Preserve | Walsh Patrick D | CA | D | P | 113 | 11.26 | 0 | 10 | 33 | 40 | D | |||||||||||||||
3/17/21 19:55 | 3/15/21 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Walsh Patrick D | MN | D | P | 132 | 32.89 | 0 | 4 | 11 | 39 | D | |||||||||||||||
11/12/20 17:11 | 11/9/20 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Walsh Patrick D | MN | D | P | 130 | 25.96 | 0 | 5 | 17 | 35 | D | |||||||||||||||
8/12/20 16:18 | 8/10/20 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Walsh Patrick D | MN | DO | CB,INTER | P | 308 | 30.78 | 0 | 10 | 50 | 30 | D | ||||||||||||||
3/25/20 13:09 | 3/23/20 | CDMO | Avid Bioservices, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Walsh Patrick D | CA | D | P | 97 | 3.22 | 0 | 30 | New | 30 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |